series-c-plus
Stage
3
Investors
About
Pherecydes Pharma is a French biotechnology company developing phage therapy, an innovative approach using bacteriophages to treat severe bacterial infections, particularly those resistant to antibiotics.
Explore Pherecydes Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.